A preferred bronchial asthma inhaler is being discontinued. Though there’s a generic model, the change may result in disruptions in care as a result of not all insurance coverage firms are masking it.
A MARTÍNEZ, HOST:
A preferred bronchial asthma inhaler is being discontinue. The drug known as Flovent will not be accessible beginning in January. And a few sufferers won’t be capable to change medicine straight away, leaving a niche of their medical care and placing them in danger for issues. NPR prescribed drugs correspondent Sydney Lupkin is right here to inform us extra about this. Sydney, how lengthy has Flovent been round?
SYDNEY LUPKIN, BYLINE: So Flovent is a reasonably widespread bronchial asthma inhaler and it has been round because the Nineteen Nineties. It is made by GSK, and it comprises a corticosteroid utilized by sufferers 4 and older to stop bronchial asthma assaults. It does that by decreasing the irritation of their airways to maintain it beneath management. So it is not an inhaler for emergency bronchial asthma assaults, it is one thing sufferers have to take twice a day. This is Kenny Mendez, the president and CEO of the Bronchial asthma and Allergy Basis of America.
KENNETH MENDEZ: Over 10 folks die a day from bronchial asthma yearly, so it is actually vital to have your bronchial asthma well-controlled. And lots of people do not realize that bronchial asthma might be deadly, so it is actually vital to just be sure you’re working together with your physician, getting the precise medicine.
MARTÍNEZ: Yeah, it is actually vital for some folks. Why is it being discontinued?
LUPKIN: So the corporate, GSK, says it is discontinuing Flovent as a result of it is making its personal generic model as a substitute, and doubtlessly saving sufferers cash by doing so. This generic does have a decrease money worth than the unique Flovent in line with the web site GoodRx. However whether or not that is really going to decrease sufferers’ prices on the pharmacy counter is extra sophisticated. This is not a typical generic made by an out of doors firm to compete towards the unique product and in the end decrease costs, that is what’s known as a licensed generic. It is made by the identical firm. This is Mendez once more.
MENDEZ: Usually, folks suppose generics ought to be cheaper, proper? I imply, that is sort of the widespread data, however it actually relies on the formulary and your insurance coverage plan and what’s lined and what’s not.
LUPKIN: So here is the problem with Flovent. In some instances, docs are saying the licensed generic is not lined. Or whether it is, sufferers should pay extra on the pharmacy counter. So some sufferers might want to change or get new prescriptions, and that is simply hoops to leap by means of that doubtlessly disrupt care.
MARTÍNEZ: So simply to be clear, it is the identical product, proper?
LUPKIN: Proper. It is the identical medicine, identical system…
LUPKIN: …Made by the identical firm. The principle distinction is that it has a clear slate by way of worth hikes. I acquired some money worth knowledge from GoodRx to get a greater look. One Flovent product was round $230 a decade in the past, now it is round $340, so virtually a 50% enhance. And with worth hikes like that, it is potential the drug firm would’ve confronted new penalties geared toward extreme worth hikes. In the meantime, the licensed generic model has solely been round a 12 months, so it is round $310. So by solely providing this new generic, GSK can promote the drug however and not using a historical past of worth hikes.
MARTÍNEZ: All proper. So what can folks do to verify they nonetheless get their medicine?
LUPKIN: Nice query. What docs and medical societies are suggesting is to bear in mind and take motion now. Fill your prescription for Flovent when you nonetheless can. Begin speaking to your physician and insurance coverage firm about choices. There are different bronchial asthma medicine if that looks like the only option for you. Each affected person and each well being plan is completely different. However it’s possible you’ll have to get the ball rolling together with your insurance coverage on issues like prior authorization, which might take time, so it is best to not wait.
MARTÍNEZ: That is NPR prescribed drugs correspondent Sydney Lupkin. Thanks so much.
LUPKIN: You guess.
(SOUNDBITE OF ANENON’S “THE COLOR WHITE”)
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content might not be in its last type and could also be up to date or revised sooner or later. Accuracy and availability might range. The authoritative document of NPR’s programming is the audio document.